(Q34002349)

30 July 2017

title

Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents (English)

1 reference

30 July 2017

0 references

1 reference

1 reference

Antonella Amendola

5

0 references

author name string

Andrea Gabbuti

1

1 reference

30 July 2017

Luisa Romanò

2

1 reference

30 July 2017

Pierluigi Blanc

3

1 reference

30 July 2017

Francesca Meacci

4

1 reference

30 July 2017

Alfonso Mele

6

1 reference

30 July 2017

Francesco Mazzotta

7

1 reference

30 July 2017

Alessandro R Zanetti

8

1 reference

30 July 2017

language of work or name

English

0 references

publication date

19 January 2007

1 reference

30 July 2017

1 reference

30 July 2017

volume

25

1 reference

30 July 2017

issue

16

1 reference

30 July 2017

page(s)

3129-3132

1 reference

Global status of hepatitis B immunisation

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.045

Hepatitis B virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.045

Integration of hepatitis B vaccination into national immunisation programmes. Viral Hepatitis Prevention Board

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.045

Vaccination against hepatitis B: the Italian strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.045

Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.045

Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.045

Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.045

Long-term protection of hepatitis B vaccine: lessons from Alaskan experience after 15 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.045

Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.045

Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.045

Persistence of anti-HBs 5 years after the introduction of routine infant and adolescent vaccination in Italy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.045

Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.045

Hepatitis B vaccination: how long does protection last?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.045

Persistence of specific antibodies after hepatitis B vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.045

Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.045

Are booster immunisations needed for lifelong hepatitis B immunity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.045

Hepatitis B vaccination: to boost or not to boost?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.045

10.1016/J.VACCINE.2007.01.045

7 January 2021

Identifiers

DOI

1 reference

30 July 2017

1 reference